XML 45 R30.htm IDEA: XBRL DOCUMENT
v3.20.4

6. FAIR VALUE MEASUREMENTS (Tables) | 12 Months Ended
--- | ---
Sep. 30, 2020
Fair Value Disclosures [Abstract] |
Table of fair value liability measured on recurring basis | The following table presents the placement in the fair value hierarchy and summarizes the change in fair value of the earn-out consideration for Fiscal 2020 and Fiscal 2019:
|  |  |  |  | Fair value measurement at reporting date using |
|  |  |  |  | Quoted prices in active markets for identical assets |  |  | Significant other observable inputs |  |  | Significant unobservable inputs |
|  | Balance |  |  | (Level 1) |  |  | (Level 2) |  |  | (Level 3) |
September 30, 2018 |  | $ | 538,000 |  |  | $ | – |  |  | $ | – |  |  | $ | 538,000 |
Increase in fair value of IPS deferred cash consideration |  |  | 36,000 |  |  |  | – |  |  |  | – |  |  |  | 36,000 |
Increase in fair value of IPS earn-out consideration |  |  | 260,000 |  |  |  | – |  |  |  | – |  |  |  | 260,000 |
September 30, 2019 |  |  | 834,000 |  |  |  | – |  |  |  | – |  |  |  | 834,000 |
Increase in fair value of IPS deferred cash consideration |  |  | 16,000 |  |  |  | – |  |  |  | – |  |  |  | 16,000 |
Decrease in the fair value of IPS earnout consideration |  |  | (350,000 | ) |  |  | – |  |  |  | – |  |  |  | (350,000 | )
Payout of IPS deferred cash consideration |  |  | (500,000 | ) |  |  | – |  |  |  | – |  |  |  | (500,000 | )
Fair value of Kablooe contingent earnout consideration |  |  | 90,000 |  |  |  | – |  |  |  | – |  |  |  | 90,000 |
September 30, 2020 |  | $ | 90,000 |  |  | $ | – |  |  | $ | – |  |  | $ | 90,000 |
Fair value assumptions | The fair value of the Kablooe contingent earn-out consideration will be measured on a recurring basis at each reporting date. The following inputs and assumptions were used in the Black-Scholes valuation model to estimate the fair value of the Kablooe earn-out consideration at September 30, 2020:
Volatility |  | 40%
Risk free interest rate |  | 1%
Expected term, in years | 0.5 - 4.5
Dividend yield |  | 0%
Schedule of Cost Method Investments | The following table presents the placement in the fair value hierarchy and summarizes the change in fair value of the cost method investment during Fiscal 2020 and Fiscal 2019:
|  |  |  |  | Fair value measurement at reporting date using |
|  |  |  |  | Quoted prices in active markets for identical assets |  |  | Significant other observable inputs |  |  | Significant unobservable inputs |
|  | Balance |  |  | (Level 1) |  |  | (Level 2) |  |  | (Level 3) |
September 30, 2019 |  | $ | 327,000 |  |  | $ | – |  |  | $ | 327,000 |  |  | $ | – |
Impairment of cost method investment |  |  | (327,000 | ) |  |  | – |  |  |  | (327,000 | ) |  |  | – |
September 30, 2020 |  | $ | – |  |  | $ | – |  |  | $ | – |  |  | $ | – |

X
- Definition Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (bbb) -URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition A tabular disclosure of (a) the aggregate carrying amount of all cost-method investments; (b) the aggregate carrying amount of cost-method investments that the investor did not evaluate for impairment for cost-method investments. + References No definition available. + Details
Name: | us-gaap_ScheduleOfCostMethodInvestmentsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration